Back to Products

Emaglin

Empagliflozin

Indications:

Type 2 diabetes mellitus: As an adjunct to diet and exercise to improve glycemic control

Risk of cardiovascular death: To reduce the risk of cardiovascular death in adult patients with T2DM and established cardiovascular disease.

Dosage & Administration:

The recommended dose of Emaglin is 10 mg once daily, taken in the morning with or without food. In patients tolerating Empagliflozin, the dose may be increased to 25 mg once daily.